IDXX

IDEXX Laboratories
D

IDXX

Arincen86/100B

IDEXX Laboratories balance sheet 1991–2026

IDEXX Laboratories had 197.54M USD in cash and short-term investments on 30 September 2026, against total debt of 972.96M USD: net debt of 775.43M USD.

Total assets Total liabilities Shareholders' equity

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
Latest
Q3 FY2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Cash and equivalents
197.54M180.07M288.27M453.93M112.55M144.45M383.93M90.33M123.79M187.68M154.90M
Short-term investments
0.000.000.000.000.000.000.000.000.00284.26M236.95M
197.54M180.07M288.27M453.93M112.55M144.45M383.93M90.33M123.79M471.93M391.85M
Cash growth
-5.11%-37.53%-36.50%+303.33%-22.09%-62.37%+325.05%-27.04%-73.77%+20.44%+14.38%
Receivables
615.80M693.19M561.32M529.53M490.90M425.58M374.74M307.49M258.53M270.07M232.17M
Inventory
390.87M377.76M381.88M380.28M367.82M269.03M209.87M195.02M173.30M164.32M158.03M
Other current assets
228.60M31.35M109.81M83.14M88.46M74.59M59.64M54.82M54.14M101.14M91.21M
Total current assets
1.50B1.34B1.40B1.50B1.10B955.66M1.06B679.64M654.17M971.99M845.58M
Property, plant and equipment
851.96M870.61M829.25M817.68M768.09M692.77M646.34M614.45M437.27M379.10M357.42M
Long-term investments
29.05M297.09M57.72M56.19M55.50M18.60M12.07M13.66M10.89M9.95M10.98M
Goodwill and intangibles
758.28M523.85M516.78M450.46M459.47M458.38M295.89M298.19M256.31M243.72M224.38M
Goodwill
640.51M414.00M405.10M365.96M361.80M359.35M243.35M239.72M214.49M199.87M178.23M
Intangible assets
117.77M109.84M111.68M84.50M97.67M99.04M52.54M58.47M41.83M43.85M46.16M
Other non-current assets
541.76M291.08M364.17M332.98M307.01M287.02M245.98M218.44M170.22M100.97M86.63M
Total assets
3.71B3.35B3.29B3.26B2.75B2.44B2.29B1.83B1.54B1.71B1.53B
Accounts payable
154.09M110.41M114.21M110.64M110.22M116.14M74.56M72.17M69.53M66.97M60.06M
Deferred revenue
40.18M35.26M33.80M37.20M37.94M40.03M42.57M41.46M41.29M29.18M27.38M
Short-term debt
549.00M500.07M417.79M325.00M653.98M148.50M49.99M288.77M398.94M655.00M611.00M
Other current liabilities
86.64M201.96M174.58M174.38M142.99M182.93M167.65M127.17M109.49M102.94M91.11M
Total current liabilities
1.26B1.15B1.07B951.55M1.24B763.58M582.76M725.34M770.44M1.00B934.57M
Long-term debt
299.88M475.99M449.79M622.88M694.39M775.21M858.49M698.91M601.35M606.08M593.11M
Other non-current liabilities
82.43M-44.62M44.34M65.53M67.59M70.94M85.60M81.16M84.83M95.72M38.94M
Lease obligations, current
26.56M0.0021.54M19.80M20.43M19.93M17.73M15.28M0.000.000.00
Lease obligations, long-term
97.53M101.15M97.84M99.67M101.24M87.38M77.04M67.47M0.000.000.00
Total liabilities
1.84B1.75B1.70B1.78B2.14B1.75B1.66B1.65B1.55B1.77B1.64B
Common stock and paid-in capital
10.88M10.84M10.78M10.75M10.72M10.69M10.65M10.57M10.51M10.43M10.33M
Retained earnings
7.33B6.39B5.33B4.44B3.60B2.92B2.18B1.60B1.17B803.55M540.40M
Accumulated other comprehensive income
-60.48M-68.84M-93.65M-71.21M-77.80M-53.48M-53.62M-46.18M-41.79M-36.47M-43.05M
Shareholders' equity
1.87B1.61B1.60B1.48B608.74M689.99M632.09M177.47M-9.51M-54.11M-108.35M
Minority interest
0.000.000.000.000.000.00707.00K352.00K280.00K264.00K139.00K
972.96M976.06M986.95M1.07B1.47B1.03B1.00B1.07B1.00B1.26B1.20B
Net cash
-775.43M-795.99M-698.68M-613.42M-1.36B-886.56M-619.32M-980.10M-876.49M-789.15M-812.26M
Working capital
235.78M191.45M331.98M543.71M-134.33M192.08M479.98M-45.70M-116.27M-32.58M-88.98M
Book value per share
23.6519.9019.1617.687.207.977.292.03-0.11-0.60-1.19
Tangible book value
1.11B1.08B1.08B1.03B149.27M231.61M336.20M-120.72M-265.83M-297.83M-332.74M
Tangible book value per share
14.0513.4112.9612.311.762.683.88-1.38-3.00-3.33-3.66
Current ratio
1.191.171.311.570.891.251.820.940.850.970.90
Debt to equity
0.520.610.620.722.411.491.596.03———

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Figures underlined with dots are from the company's SEC filings, where our data provider's differ.

Common questions about IDEXX Laboratories's cash and debt

Source: Financial Modeling Prep